KADAPA: Lomada Dakshayani, an associate professor of Yogi Vemana University in Kadapa, has garnered acclaim for her talent and research. With 14 years of teaching experience and 23 years of research expertise, she has made contributions to the fields of cancer biology, autoimmune diseases and nanotechnology.
From humble beginnings at SKR&SKR Women’s Degree College in Kadapa to scaling the heights of scientific achievement, Dakshayani’s journey exemplifies perseverance and relentless pursuit of excellence. As she continues to push the boundaries of research, her endeavour serves as a beacon of hope for patients battling cancer and autoimmune disorders worldwide.
During her tenure as a post-doctoral fellow at the University of Texas MD Anderson Cancer Center, she had conducted a research on the development of a HIV and HPV peptide cocktail vaccine, utilising a mutant cholera toxin as a mucosal adjuvant.
Her research had demonstrated enhanced immune responses in mice, laying the foundation for breakthroughs in vaccine development. Her research interests extend to molecular mechanisms involved in immune system regulation and disease pathogenesis. She had received the National Teachers’ Day Award in 2023.
Moreover, she has been adorned with accolades such as the Raman Fellowship for Post-Doctoral Research in the US and the DST Young Scientist Award. Beyond her research prowess, Dakshayani is a dedicated member of various scientific organisations.
She emphasises the transformative potential of nanotherapy in augmenting the immune system’s ability to combat diseases. By harnessing the intricate network of cells within the immune system, she envisions a future where overactive immune responses and cancer cells can be targeted with precision.